Unexpected complexity of multidrug resistance in the mcr-1-harbouring Escherichia coli

Science China Life Sciences

Volumn 59, Issue 7, 2016, Pages 732-734

  Gao, Rongsui ^a   Li, Yue ^b   Lin, Jingxia ^a   Tan, Chen ^b   Feng, Youjun ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

BACTERIAL GENE; DRUG EFFECTS; ESCHERICHIA COLI; GENETICS; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS;

EID: 84968547007     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-016-5070-1     Document Type: Letter

References (8)

1. Du, H., Chen, L., Tang, Y.W., and Kreiswirth, B.N. (2016). Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis 16, 287–288.
2. Hasman, H., Hammerum, A.M., Hansen, F., Hendriksen, R.S., Olesen, B., Agerso, Y., Zankari, E., Leekitcharoenphon, P., Stegger, M., Kaas, R.S., Cavaco, L.M., Hansen, D.S., Aarestrup, F.M., and Skov, R.L. (2015). Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill 20, ES.2015.20.49.30085.
3. Liu, Y.Y., Wang, Y., Walsh, T.R., Yi, L.X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., Yu, L.F., Gu, D., Ren, H., Chen, X., Lv, L., He, D., Zhou, H., Liang, Z., Liu, J.H., and Shen, J. (2016). Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16, 161–168.
4. Nation, R.L., Li, J., Cars, O., Couet, W., Dudley, M.N., Kaye, K.S., Mouton, J.W., Paterson, D.L., Tam, V.H., Theuretzbacher, U., Tsuji, B.T., and Turnidge, J.D. (2015). Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis 15, 225–234.
5. Paterson, D.L., and Harris, P.N. (2016). Colistin resistance: a major breach in our last line of defence. Lancet Infect Dis 16, 132–133.
6. Malhotra-Kumar, S., Xavier, B.B., Das, A.J., Lammens, C., Butaye, P., and Goossens, H. (2016). Colistin resistance gene mcr-1 harboured on a multidrug resistant plasmid. Lancet Infect Dis 16, 283–284.
7. Yao, X., Doi, Y., Zeng, L., Lv, L., and Liu, J.H. (2016). Carbapenemresistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis 16, 288–289.
8. Ye, H., Li, Y., Li, Z., Gao, R., Zhang, H., Wen, R., Gao, G.F., Hu, Q., and Feng, Y. (2016). Diversified mcr-1-harbouring plasmid reservoirs confer resistance to colistin in human gut microbiota. MBio 7, pii: e00177–16. doi: 10.1128/mBio.00177-16